Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
- PMID: 8710899
- PMCID: PMC38701
- DOI: 10.1073/pnas.93.16.8502
Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
Abstract
The development of new capillary networks from the normal microvasculature of the host appears to be required for growth of solid tumors. Tumor cells influence this process by producing both inhibitors and positive effectors of angiogenesis. Among the latter, the vascular endothelial growth factor (VEGF) has assumed prime candidacy as a major positive physiological effector. Here, we have directly tested this hypothesis in the brain tumor, glioblastoma multiforme, one of the most highly vascularized human cancers. We introduced an antisense VEGF expression construct into glioblastoma cells and found that (i) VEGF mRNA and protein levels were markedly reduced, (ii) the modified cells did not secrete sufficient factors so as to be chemoattractive for primary human microvascular endothelial cells, (iii) the modified cells were not able to sustain tumor growth in immunodeficient animals, and (iv) the density of in vivo blood vessel formation was reduced in direct relation to the reduction of VEGF secretion and tumor formation. Moreover, revertant cells that recovered the ability to secrete VEGF regained each of these tumorigenic properties. These results suggest that VEGF plays a major angiogenic role in glioblastoma.
Similar articles
-
Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.Oncogene. 1999 Aug 26;18(34):4860-9. doi: 10.1038/sj.onc.1202869. Oncogene. 1999. PMID: 10490819
-
Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.Am J Pathol. 1997 Dec;151(6):1523-30. Am J Pathol. 1997. PMID: 9403702 Free PMC article.
-
Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts.Cancer Res. 1998 Sep 15;58(18):4185-92. Cancer Res. 1998. PMID: 9751633
-
[Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2002 Mar;34(2):165-70. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2002. PMID: 12006990 Chinese.
-
Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity.Jpn J Cancer Res. 1996 Sep;87(9):963-71. doi: 10.1111/j.1349-7006.1996.tb02127.x. Jpn J Cancer Res. 1996. PMID: 8878460 Free PMC article.
Cited by
-
Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes.Mol Cancer Res. 2012 Jun;10(6):739-49. doi: 10.1158/1541-7786.MCR-11-0483. Epub 2012 Apr 19. Mol Cancer Res. 2012. PMID: 22516348 Free PMC article.
-
Ca2+ as a therapeutic target in cancer.Adv Cancer Res. 2020;148:233-317. doi: 10.1016/bs.acr.2020.05.003. Epub 2020 Jul 9. Adv Cancer Res. 2020. PMID: 32723565 Free PMC article. Review.
-
Expression of vascular endothelial growth factor by human renal cancer cells enhances angiogenesis of primary tumors and production of ascites but not metastasis to the lungs in nude mice.Clin Exp Metastasis. 1999;17(10):831-40. doi: 10.1023/a:1006792007063. Clin Exp Metastasis. 1999. PMID: 11089881
-
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.Am J Pathol. 2003 Jun;162(6):1913-26. doi: 10.1016/S0002-9440(10)64325-8. Am J Pathol. 2003. PMID: 12759248 Free PMC article.
-
Current Challenges and Opportunities in Treating Glioblastoma.Pharmacol Rev. 2018 Jul;70(3):412-445. doi: 10.1124/pr.117.014944. Pharmacol Rev. 2018. PMID: 29669750 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources